New mRNA vaccine could reduce the recurrence and spread of skin cancer
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine.
NPR's Leila Fadel talks to Dr.
Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.npr.org — the content belongs to NPR Health.
